Results 101 to 110 of about 795 (185)

Prior treatment, not vitamin D, predicts romosozumab response in 314 osteoporosis patients: A retrospective cohort study. [PDF]

Bone Rep
Nakano R, Ichisawa A, Saruta K, Kogawa M, Fukuda A.   +4 more
europepmc   +1 more source

Mechanistic actions of eldecalcitol and alfacalcidol across the muscle-metabolic axis: A selectivity perspective in sarcopenia and type 2 diabetes. [PDF]

iScience
Cambria MT, Campanella M, Russo C, Agafonova A, Surdo S, Valle MS, Malaguarnera L.   +6 more
europepmc   +1 more source

Romosozumab Treatment After Parathyroidectomy for Primary Hyperparathyroidism-Complicated Osteoporosis: A Two-Case Report. [PDF]

AACE Endocrinol Diabetes
Takebe S, Seki Y, Morimoto S, Watanabe D, Ichihara A.   +4 more
europepmc   +1 more source

Mechanically stable but biologically inactive Jones fracture nonunion managed without immediate revision surgery: a case report. [PDF]

J Med Case Rep
Nozaka K, Shirahata T, Yuasa Y, Harata S, Nakanishi M, Miyakoshi N.   +5 more
europepmc   +1 more source

Vitamin D for type 2 diabetes prevention: cost-effective, but not yet cost-saving. [PDF]

Lancet Reg Health Am
Zhang J, Zhan X, Li T.
europepmc   +1 more source

Efficacy and safety of doxercalciferol (1α hydroxyvitamin D₂) on spine and femur bone mineral density in postmenopausal osteopenic women. [PDF]

Front Endocrinol (Lausanne)
Gallagher JC, Mazess R.
europepmc   +1 more source

Denosumab increased bone mineral density but caused marked serum calcium fluctuations in a patient undergoing peritoneal dialysis. [PDF]

CEN Case Rep
Yamada S, Enomoto S, Matsuo K, Sonezaki Y, Torisu K.   +4 more
europepmc   +1 more source

Additive effects of active vitamin D3 or vitamin E administration on therapeutic lower-limb home exercise for knee osteoarthritis: A pilot prospective randomized controlled trial. [PDF]

Medicine (Baltimore)
Kanazawa H, Kurosawa H, Nagao M, Koike M, Miyagawa K, Ozaki Y, Iwase Y, Ishijima M.   +7 more
europepmc   +1 more source

An Open-Label, Randomized Pharmacokinetic Study of Two Formulations of Eldecalcitol Capsules Following Single Oral Administration in Healthy Chinese Volunteers Under Fasting and Fed Conditions

, 2022
Yueyue Liu, JUAN WU, Hui Zhao, Wei Hu, Yuru Fan, Liang Zheng, Qian Zhang, Chenlin Shen   +7 more
core   +1 more source

Eldecalcitol (ED-71) alleviates oral squamous cell carcinoma progression by suppressing GPX1 expression through NF-κB pathway

Bone Reports, 2020
Yuan Gao, Yupu Lu, Minqi Li
doaj   +1 more source